AzTrials
AzTrials

Acute Kidney InjuryNCT03727204

Acute Kidney Injury After Cardiac Surgery: Novel Ultrasound Techniques for Prediction of Acute Kidney Injury

An observational study of Acute Kidney Injury and Acute Renal Failure, run by Aarhus University Hospital at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Acute Kidney Injury (AKI) is a frequent and important complication to cardiac surgery. This study will evaluate the diagnostic ability of ultrasonographic measures of blood flow in kidneys and liver in predicting AKI after cardiac surgery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
On-pump cardiac surgery
Type of treatment
Surgery or procedure
How many people
150 participants
Where
2 sitesin 2 countries
Study dates
15 Oct 2018to 31 Mar 2020
How long will I take part?
1 Month
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients scheduled for on-pump cardiac surgery at the Department of Cardiothoracic \& vascular surgery, Aarhus University Hospital. The study will include 100 patients from Denmark.

Who may be able to join

  • All patients ≥ 18 years
  • Scheduled for on-pump cardiac surgery
  • Oral and written consent
  • AND
  • 1 of the following risk factors for development of postoperative AKI may be included:
  • age > 70 years;
Show all 16Show fewer
  • NYHA (New York Heart Association) 3+4;
  • Insulin dependent diabetes;
  • Glomerular filtration rate < 60 ml/min/1,73 m2;
  • Ejection fraction < 35;
  • Surgery:
  • Combined CABG and valve surgery;
  • Any valve surgery except isolated aortic-valve surgery;
  • Redo surgery;
  • Endocarditis;
  • Peripheral vascular disease.

Who cannot join

  • Insufficient ultrasonographic imaging of the kidneys;
  • Known morphological kidney disease;
  • Preoperative dialysis;
  • Prior participation in the study.

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Denmark1 site
  • Aarhus University Hospital, Department of Anaesthesiology

    Aarhus, 8200

Other trials in Denmark

South Africa1 site
  • Department of Anesthesiology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand

    Johannesburg, 2196

Other trials in South Africa

About this study

Acute Kidney Injury (AKI) is a frequent and important complication to cardiac surgery. This study will evaluate the diagnostic ability of ultrasonographic measures of blood flow in kidneys and liver in predicting AKI after cardiac surgery.

Read the detailed description

Acute Kidney Injury (AKI) is a frequent and important complication to cardiac surgery. The pathophysiology is multifactorial, but renal functions in this setting is determined by a complex interplay between renal perfusion, fluid status, cardiac output, mean arterial pressure and back pressure to venous outflow.

Renal perfusion may be quantified with novel ultrasound techniques. Ultrasonography of the kidney and renal vasculature allows for assessment of renal afferent flow and renal venous flow and, together with venous flow patterns of the portal vein and liver veins, may identify patients in risk of AKI.

The study is observational and will describe the diagnostic accuracy of the ultrasound measures in predicting postoperative AKI. Patients will be examined with ultrasound of kidney and liver flow along with echocardiography on on the day before surgery and on the 1st and 4th. In addition, patients are followed with markers of kidney function, fluid balance and invasive measures of mean arterial pressure and central venous pressure.

Being tested
On-pump cardiac surgery
Keywords
Ultrasound, Ultrasonographic flow measures, Fluid treatment
Medical subject headings
Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • On-pump cardiac surgeryProcedure or surgery

    All participants will undergo on-pump cardiac surgery

Study groups in NCT03727204
Study groupRoleWhat they receive
Aarhus University Hospital100 patients undergoing on-pump cardiac surgery at Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand
Receives: Procedure: On-pump cardiac surgery
Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand50 patients undergpoing on-pump cardiac surgery at at Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand
Receives: Procedure: On-pump cardiac surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The association between the kidney venous ultrasonography flow pattern category on the 1st postoperative day and acute kidney injury (AKI) on the 4th postoperative day.

    The flow pattern is grouped as either continuous, biphasic or monophasic based on the appearance.The final analysis will possibly include other flow categories.

    AKI is defined by the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) criteria and graded in four stages from no AKI to stage 1-3 AKI based on serum creatinin change and/or changes in urine output, with stage 3 being the worst stage.

    Measured: 4 days

Secondary outcomes (6)
  1. Correlation between changes in organ-specific flow measurements and the corresponding biomarkers.

    Correlations between organ-specific ultrasonography flow measurements and the corresponding biomarkers of kidneys, liver and heart function, for both absolute values of organ-specific flow and perioperative changes in organ-specific flow

    Measured: 1 month

  2. Establishment of the most optimal organ specific cut-off values and the development of AKI.

    Establishment of the most optimal cut-off (threshold) values for

    • absolute ultrasonography flow values for respectively kidney arterial flow; kidney venous flow; liver vein flow; portal vein flow and the risk of development of AKI.
    • changes in ultrasonography flow values for respectively kidney arterial flow; kidney venous flow; liver vein flow; portal vein flow and the risk of development of AKI.

    Measured: 1 month

  3. Fluid balance and AKI

    Correlations between accumulated fluid balance on the 1st postoperative day and the development of AKI on the 4th postoperative day.

    Measured: 1 month

  4. Diastolic dysfunction and AKI

    Correlations between echocardiographic measures of diastolic dysfunction and AKI. The measures include mitral inflow (E and A), mitral annular motion, medial and lateral (e' and a'), and measures define grades of diastolic dysfunction from normal to grade I-III, with grade III being the worst.

    Measured: 1 month

  5. Organ-specific flow measures and mortality

    Correlation between organ-specific ultrasonography flow measurements on the day before surgery, the 1st and 4th postoperative day and the mortality at the 1st, 4th and 28th postoperative day.

    Measured: 1 month

  6. Organ-specific flow measures and and time of stay in ICU and hospital

    Correlation between organ-specific ultrasonography flow measurements on the day before surgery, the 1st and 4th postoperative day and the duration of intensive care stay and duration of hospital stay.

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2018
  2. Study start15 Oct 2018
  3. Primary completion31 Mar 2020
  4. Study completion31 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (actual)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT03727204
Sponsor's protocol ID
1-10-72-267-18
Status last verified
Apr 2021
First submitted
9 Oct 2018
Last updated
13 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury and Acute Renal Failure, run by Aarhus University Hospital at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark, South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The association between the kidney venous ultrasonography flow pattern category on the 1st postoperative day and acute kidney injury (AKI) on the 4th postoperative day. (time frame: 4 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in